CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos
In 2016, the EGF-Predictor Phase IV Clinical Trial Opening Workshop was held in Cienfuegos, sponsored by the Center for Molecular Immunology of Havana which coexist with other clinical trials. The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic va...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Universidad de las Ciencias Médicas de Cienfuegos,
2017-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|